NUEVDI
Live / Allowed — Notice of allowance issued (as of 25 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Apr 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99743004
- Mark type
- Word mark
- Filed
- 03 Apr 2026
- Published for opposition
- 30 Jun 2026
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, Generalized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD)
Owner
- Definium Therapeutics US, Inc., New York, NY, US
- Definium Therapeutics US, Inc., New York, NY, US
Prosecution history
- 25 Aug 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jun 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jun 2026 — PUBLISHED FOR OPPOSITION
- 24 Jun 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Jun 2026 — ASSIGNED TO EXAMINER
- 03 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 03 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Apr 2026 — NEW APPLICATION ENTERED